This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rensselaer Polytechnic Institute. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Navdeep Grover in Biosynthetic Heparin
Introduction
Navdeep Grover is an accomplished inventor based in Troy, NY (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of heparin. His work focuses on creating a biosynthetic version of heparin that is bioequivalent to porcine USP Heparin Sodium.
Latest Patents
Navdeep Grover holds one patent related to his innovative work. The patent involves the synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis process includes three intermediates starting from heparosan, showcasing his expertise in biochemical synthesis.
Career Highlights
Navdeep Grover is affiliated with Rensselaer Polytechnic Institute, where he continues to advance his research and development efforts. His work has the potential to impact medical treatments and improve patient outcomes through the use of synthetic heparin.
Collaborations
Navdeep has collaborated with notable colleagues, including Marc Douaisi and Payel Datta. These collaborations enhance the research environment and contribute to the advancement of innovative solutions in the field.
Conclusion
Navdeep Grover's contributions to the synthesis of biosynthetic heparin represent a significant advancement in biochemistry. His work not only highlights his innovative spirit but also has the potential to improve medical treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile